NASDAQ:SNGX

Soligenix Stock Predictions

etoro logo Buy SNGX
*Your capital is at risk
$0.483
-0.266 (-35.48%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SNGX Prediction Chart

SNGX Predictions History

Latest community submissions for SNGX.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 3, 2025 Bullish $1.55 X 0
Oct 10, 2025 $1.68 -6.20% $1.68 V 99.94% 10
Oct 10, 2025 $1.72 -3.88% $1.68 V 97.58% 1
Oct 10, 2025 Bullish $1.68 X 0
Jul 22, 2024 $6.57 +8.22% $5.15 X 72.44% 0
Jul 22, 2024 $6.38 +5.14% $5.15 X 76.08% 0
Jul 22, 2024 Bullish $5.15 X 0
Jan 17, 2024 $0.756 -93.34% $0.634 X 80.82% 0
Jan 17, 2024 $0.739 -93.50% $0.634 X 83.55% 0
Jan 17, 2024 $0.350 -97.39% $0.634 V 55.17% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SNGX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SOLIGENIX, INC
Soligenix
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE